Table 1.
Attrition criterion | N | Percent |
---|---|---|
At least one spinal cord injury (SCI) diagnosis during January 1, 2006–June 30, 2011 | 46,931 | 100.0 |
Continuous medical and pharmacy benefit enrollment 6 months prior to first SCI diagnosis | 19,449 | 41.4 |
No SCI diagnosis during the 6 months before the first SCI diagnosis | 16,774 | 35.7 |
No neuropathic pain (NeP) diagnosis or NeP-related drugs during the 6 months before the first SCI diagnosis | 11,705 | 24.9 |
NeP diagnosis or NeP-related drug within 12 months following first SCI diagnosis (NeP index event)a | 1,603 | 3.4 |
Continuous medical and pharmacy benefit enrollment 6 months prior to NeP index event | 1,542 | 3.3 |
Continuous medical and pharmacy benefit enrollment 12 months following NeP index event | 1,116 | 2.4 |
No evidence of seizure disorders, multiple sclerosis, amyotrophic lateral sclerosis, diabetic peripheral neuropathy, postherpetic neuralgia, or related medications during pre or postindex periods | 708 | 1.5 |
Age ≥18 years of age at date of first found SCI event | 581 | 1.2 |
Patients included in final SCI-NeP cohort after propensity score matching processa | 546 | 1.2 |
Note:
Matched patients had no evidence of NeP diagnosis or NeP-related drugs between January 1, 2005 and June 30, 2012, but otherwise the same selection criteria as the matched SCI-NeP patients.